Gary Gintant's Biography

Gary Gintant, Senior Research Fellow, Abbvie

Dr. Gary Gintant is Senior Research Fellow in the Dept. of Integrative Pharmacology, Integrated Science and Technology, at AbbVie. He is involved in multiple internal drug discovery and safety initiatives internally; external activities include various cardiac safety initiatives (such as ILSI/HESI Proarrhythmia Models Project, the Cardiac Safety Research Consortium, and the Comprehensive in Vitro Proarrhythmia Assay Initiative) while serving on various journal editorial boards, NIH study sections, and Safety Pharmacology Society committees. Research interests include cardiovascular pharmacology, cellular electrophysiology/ion channels, arrhythmias, application of stem-cell derived cells and tissues to drug discovery efforts, and translational medicine. He gained his MA, M.Phil. and PhD degrees from the College of Physicians and Surgeons of Columbia University.

Present (and Future) Uses for Stem Cells Derived Preparations in Drug Discovery and Toxicity Testing

Monday, 10 July 2017 at 13:30

Add to Calendar ▼2017-07-10 13:30:002017-07-10 14:30:00Europe/LondonPresent (and Future) Uses for Stem Cells Derived Preparations in Drug Discovery and Toxicity TestingStem Cells for Drug Discovery and Toxicity Screening 2017 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

The advent of human pluripotent stem cells a decade ago sparked visions of novel screening approaches for drug safety and efficacy, narrowing the translational gap between traditional preclinical and clinical studies, and defining a new “proclinical space” where human derived preparations are used in preclinical assays. Not unlike other novel (and potentially disruptive) technologies, limitations learned along the way have provided new challenges for both the biology and technologies necessary for confident and efficient screening efforts. This presentation will highlight promising present and future applications for stem cell derived preparations, focusing on prospects for achieving translational success of new drug candidates.

Add to Calendar ▼2017-07-10 00:00:002017-07-11 00:00:00Europe/LondonStem Cells for Drug Discovery and Toxicity Screening 2017Stem Cells for Drug Discovery and Toxicity Screening 2017 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors